Navigation Links
Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
Date:5/24/2011

l tolerated in the two studies. In one study, 55.8% of patients had adverse events (AEs) with ACZ885 vs. 38.3% with TA(16). In the other study, 54.5% of patients had AEs with ACZ885 vs. 50.9% with TA(17). Serious adverse events (SAEs), 10 for ACZ885 vs. five for TA in one study and three for ACZ885 vs. one for TA in the other study, were not considered to be related to study medication by the investigators(16,17).

About ACZ885ACZ885 is a fully human monoclonal antibody that inhibits interleukin-1 beta (IL-1 beta), which is part of the body's immune system defenses(19). Excessive production of IL-1 beta plays a major role in many inflammatory diseases, including gouty arthritis(19). ACZ885 works by neutralizing IL-1 beta for a sustained period of time, therefore inhibiting inflammation(10).

DisclaimerThe foregoing release contains forward-looking statements that can be identified by terminology such as "may", "will", "committed", "potential" or similar expressions, or by express or implied discussions regarding potential new indications or labeling for ACZ885 or regarding potential future revenues from ACZ885. You should not place undue reliance on these statements.  Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with ACZ885 to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that ACZ885 will be approved for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that ACZ885 will achieve any particular levels of revenue in the future. In particular, management's expectations regarding ACZ885 could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, incl
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 According to ... Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application ... - Global Forecasts to 2019", published by MarketsandMarkets, studies ... period of 2014 to 2019. The market is ... CAGR of 9.6% from 2014 to 2019. ...
(Date:9/23/2014)... , Sept. 23, 2014 A case report ... a SynCardia temporary Total Artificial Heart into a patient ... ventricles were reversed, along with other abnormalities. ... modifying the SynCardia Total Artificial Heart to treat a ... report and video in the Journal of Visualized Experiments ...
(Date:9/23/2014)... Calif. , Sept. 23, 2014  Savant ... today confirmed the initiation of human safety testing ... of addiction. A single dose of 18-MC, administered ... study conducted by Savant,s South American partner, was ... drug. Savant HWP plans to develop 18-MC as ...
Breaking Medicine Technology:Ablation Technologies Market Worth $3.81 Billion by 2019 2Ablation Technologies Market Worth $3.81 Billion by 2019 3Ablation Technologies Market Worth $3.81 Billion by 2019 41st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 21st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 31st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 4Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3
... March 15, 2011 Omeros Corporation (Nasdaq: ... and commercializing products focused on inflammation, bleeding and disorders ... for the fourth quarter and year ended December 31, ... for the three months ended December 31, 2010 were ...
... Pharmacy Benefit Consulting, the nation,s leading Pharmacy Benefit ... their clients. On February 16th, ARMSRx ... Lumber.  It was recommended and modeled by ARMSRx last ... making some simple changes.  The results speak for themselves. ...
Cached Medicine Technology:Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results 2Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results 3Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results 4Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results 5Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results 6ARMSRx and 84 Lumber Hammer Down Rx Costs...Again 2
(Date:9/23/2014)... remedy stress: You just need a breath of fresh air. ... , Turns out all those things combined may in fact ... new large scale study suggests. , Group nature walks are ... mental health and well-being, according to the study conducted by ... James Hutton Institute, and Edge Hill University in the United ...
(Date:9/23/2014)... a minimally invasive procedure to remove the gallbladder, is ... U.S. Yet medical centers around the country vary in ... quickly into surgery while others wait. , In a ... of Surgery , researchers found gallbladder removal surgery can ... patients into the operating room at night. , ...
(Date:9/23/2014)... UPTON, NYMuch of our understanding of how living things ... that catalyze the processes of life, the receptors that ... the nucleic acids DNA and RNA that carry genetic ... To give scientists unprecedented access to these structural details, ... of Health (NIH) and the U.S. Department of Energy ...
(Date:9/23/2014)... ADOMANI, Inc. has announced that industry ... He is a 13-year veteran in the school, commercial and ... A-Z Bus Sales of Colton, California. While with A-Z Mr. ... top line revenues, profit and market penetration by double digits. ... to all-electric or plug-in hybrid vehicle conversions. They have ...
(Date:9/23/2014)... of Cancer presents detailed reports on the wide ... Survivorship Summit held this past January in Brussels, Belgium. ... treatments has boosted survival rates of patients with cancer ... of cancer survivors. Despite this good news, cancer survivors ... adverse treatment effects and some must also deal with ...
Breaking Medicine News(10 mins):Health News:Beating stress outdoors? Nature group walks may improve mental health 2Health News:Study finds gallbladder surgery can wait 2Health News:New NIH/DOE grant for life science studies at NSLS-II 2Health News:New NIH/DOE grant for life science studies at NSLS-II 3Health News:ADOMANI Announces Jim Reynolds to Take Over as President and CEO 2
... sufficiency, new, antimicrobial-susceptibility system/panels for MRSA and other pathogens, ... and enhanced automated laboratory systems, ... will also be on view, WASHINGTON, July 29 ... will see Magellan Biosciences, continued,emergence as a new leader in ...
... people with disabilities when facing increasing healthcare costs, including added ... ... Belleville, IL (PRWEB) July 29, 2008 –- Rising ... a financial overload for families, according to http://allsup.com/Home.aspx ...
... Healthcare of Atlanta Signs Multi-Year Agreement with PureWellness to Provide ... ... Burlington, VT (PRWEB) July 29, 2008 -- PureWellness, ... solutions], announced it has signed an agreement with Children,s Healthcare ...
... a breakthrough test on its mesothelioma blog, which will allow early detection ... cancer kills a patient so quickly is due to the fact that ... ... -- LegalView, the most comprehensive legal resource available on the web, informed ...
... Database Now Offers Early Access to Research From ... and citation database of,peer-reviewed literature, today announced that ... papers published,prior to being printed, from journals produced ... Group (NPG). In the fall, AiPs,from BioMed Central ...
... age of your neighborhood may influence your risk of obesity, according ... The study, to be ... Preventive Medicine , linked the body mass index (BMI) of nearly ... The study found that residents were at less risk of being ...
Cached Medicine News:Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 2Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 3Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 4Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 5Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 2Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 3Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 4Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 5Health News:Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program 2Health News:Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program 3Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 2Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 3Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 4Health News:Scopus Adds Pre-Print Research Abstracts From Four Prestigious Publishers 2Health News:Scopus Adds Pre-Print Research Abstracts From Four Prestigious Publishers 3Health News:This old healthy house 2
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
... The economical way to order tips. ... of 1000 tips). Also available in easy-to-open, ... pack. Bulk Packs are sealed with a ... for quick access to Gilsons Diamond Tips. ...
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
Medicine Products: